Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India

BACKGROUND: Over the years, there has been introduction of newer drugs, like bendamustine and ibrutinib, for the management of chronic lymphocytic leukaemia (CLL). Though these drugs lead to better survival, they are also associated with higher cost. The existing evidence on cost effectiveness of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehra, Prerika, Chauhan, Akashdeep Singh, Malhotra, Pankaj, Kumar, Lalit, Singh, Ashish, Gupta, Nidhi, Mehra, Nikita, Mathew, Anisha, Kataki, Amal Chandra, Gupta, Sudeep, Prinja, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305972/
https://www.ncbi.nlm.nih.gov/pubmed/37383548
http://dx.doi.org/10.1016/j.lansea.2023.100201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305972/
https://www.ncbi.nlm.nih.gov/pubmed/37383548
http://dx.doi.org/10.1016/j.lansea.2023.100201

Ejemplares similares